WANA (Jul 10) – The Deputy for Technical Affairs and New Technologies at the Iranian Blood Transfusion Organization has announced the development of a highly advanced blood irradiation device in collaboration with the Atomic Energy Organization of Iran. The domestically manufactured device is described as a major step forward in providing safe blood products for patients, and production will begin following final approval.

 

The Deputy for Technical Affairs and New Technologies at the Iranian Blood Transfusion Organization , Dr. Ebadollah Salek-Moghaddam, emphasized that the blood irradiation device is a critical tool in the preparation of certain blood components.

 

“Only two or three countries have successfully developed this level of technology. This device is highly sensitive; even slight overexposure to radiation can destroy the blood product and render it ineffective,” he said.

 

According to Dr. Salek-Moghaddam, technical evaluations conducted by the Blood Transfusion Organization have shown that the Iranian-made device performs on par with international models.

 

“The device will soon be installed at the Tehran Blood Transfusion Center for final assessments. Upon approval, it will enter mass production to meet national needs,” he added.

 

Some blood products require irradiation before transfusion, especially in cases involving immunocompromised patients or premature infants.

 

“If not irradiated, the transfusion can cause graft-versus-host disease (GVHD), a condition that is 100% fatal. This makes the use of such technology critically important,” he explained.

 

Dr. Salek-Moghaddam also noted that due to the device’s use of radioactive materials, special infrastructure and regulatory approval are required for its installation.

 

These preparations are already underway, with technical input from the Atomic Energy Organization. Once the device passes all regulatory and technical standards, the necessary units will be produced to supply the country’s medical network.